Atorvastatin-Induced Necrotizing Myopathy and its Response to Combination Therapy

被引:4
|
作者
Boppana, Sri Harsha [1 ]
Syed, Hasan A. [2 ]
Antwi-Amoabeng, Daniel [2 ]
Reddy, Prahlad [3 ]
Gullapalli, Nageshwara
机构
[1] Univ Nevada, Internal Med, Reno, NV 89557 USA
[2] Univ Nevada, Internal Med, Reno Sch Med, Reno, NV 89557 USA
[3] Arthrit Consultants, Rheumatol, Reno, NV USA
关键词
atorvastatin; myopathy; ANTI-HMGCR ANTIBODIES; AUTOIMMUNE MYOPATHY; HISTORY; STATINS;
D O I
10.7759/cureus.12957
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atorvastatin is the most commonly used stalin medication to decrease cholesterol levels and prevent atherosclerosis. Myopathy is a reported side effect of atorvastatin which can happen even after more than six months after starting the medication. The side effect on the muscle tissue can range from simple reversible myalgia to respiratory muscle compromise. Here we present a 46-year-old male who presented with myopathy after taking atorvastatin for two years. Biopsy proved immune-mediated necrotizing myopathy which responded to a combination of Rituximab and intravenous immunoglobulin therapy.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] An atorvastatin-induced positive anti-HMGCR immune-mediated necrotizing myopathy case
    Chaisrimaneepan, Nattanicha
    Thongpiya, Jerapas
    Yingchoncharoen, Pitchaporn
    Saowapa, Sakditad
    CLINICAL CASE REPORTS, 2024, 12 (03):
  • [2] Elucidation of the mechanism of atorvastatin-induced myopathy in a rat model
    El-Ganainy, Samar O.
    El-Mallah, Ahmed
    Abdallah, Dina
    Khattab, Mahmoud M.
    El-Dina, Mahmoud M. Mohy
    El-Khatib, Aiman S.
    TOXICOLOGY, 2016, 359 : 29 - 38
  • [3] Genetic predisposition to atorvastatin-induced myopathy: a case report
    Notarangelo, M. Francesca
    Marziliano, N.
    Demola, M. Antonietta
    Pigazzani, F.
    Guidorossi, A.
    Merlini, P. Angelica
    Ardissino, D.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (05) : 604 - 606
  • [4] Atorvastatin-induced dermatomyositis
    Noël, B
    Cerottini, JP
    Panizzon, RG
    AMERICAN JOURNAL OF MEDICINE, 2001, 110 (08): : 670 - 671
  • [5] Atorvastatin-induced polyneuropathy
    Jacobs, MB
    ANNALS OF INTERNAL MEDICINE, 2004, 141 (01) : 77 - 77
  • [6] Atorvastatin-induced polyneuropathy
    Silverberg, C
    ANNALS OF INTERNAL MEDICINE, 2003, 139 (09) : 792 - 793
  • [7] Atorvastatin-induced dermatomyositis
    Mert Oztas
    Serdal Ugurlu
    Ovgu Aydin
    Rheumatology International, 2017, 37 : 1217 - 1219
  • [8] Atorvastatin-Induced Eosinophilia
    Choubey, Ankur P.
    Alqahtani, Ali
    Verghese, Cherian
    AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (06) : E811 - E812
  • [9] Atorvastatin-induced dermatomyositis
    Oztas, Mert
    Ugurlu, Serdal
    Aydin, Ovgu
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (07) : 1217 - 1219
  • [10] Atorvastatin-induced pancreatitis
    Prajapati, Samir
    Shah, Samidh
    Desai, Chetna
    Desai, Mira
    Dikshit, R. K.
    INDIAN JOURNAL OF PHARMACOLOGY, 2010, 42 (05) : 324 - 325